|
|
|
(State or Other Jurisdiction
of Incorporation or Organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Item 8.01
|
Other Events.
|
Item 9.01
|
Financial Statements and Exhibits
|
Exhibit Number
|
Description
|
|
Opinion of Dechert LLP.
|
||
Consent of Dechert LLP (included in Exhibit 5.1).
|
||
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Dated: September 7, 2022
|
Aquestive Therapeutics, Inc.
|
|
By:
|
/s/ A. Ernest Toth, Jr.
|
|
Name: A. Ernest Toth, Jr.
|
||
Title: Chief Financial Officer
|
1095 Avenue of the Americas
New York, NY 10036-6797
+1 212 698 3500 Main
+1 212 698 3599 Fax
www.dechert.com
|
Re:
|
Prospectus Supplement to Registration Statement on Form S-3
|
(i)
|
the Registration Statement;
|
(ii)
|
the Prospectus Supplement;
|
(iii)
|
the Company’s Amended and Restated Certificate of Incorporation, as originally filed with the Secretary of State of the State of Delaware on July 27,
2018;
|
(iv)
|
the Company’s Amended and Restated Bylaws, effective as of July 24, 2018;
|
(v)
|
a Certificate of Good Standing with respect to the Company issued by the Secretary of State of the State of Delaware, as of a recent date;
|
(vi)
|
the Equity Distribution Agreement; and
|
(vii)
|
the resolutions of the board of directors of the Company, relating to, among other things, (a) the authorization and approval of the preparation and
filing of the Registration Statement, the Prospectus and the Prospectus Supplement and (b) the authorization to enter into and amend the Equity Distribution Agreement.
|
Very truly yours,
|
|
/s/ Dechert LLP
|